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The EPIBEL Study: Outcomes to Discharge From Hospital for
Extremely Preterm Infants in Belgium
Piet Vanhaesebrouck, MD, PhD*; Karel Allegaert, MD‡; Jean Bottu, MD§; Christian Debauche, MD;
Hugo Devlieger, MD, PhD‡; Martine Docx, MD¶; Anne Franc¸ois, MD#; Dominique Haumont, MD**;
Jacques Lombet, MD‡‡; Jacques Rigo, MD, PhD‡‡; Koenraad Smets, MD, PhD*;
Inge Vanherreweghe, MD**; Bart Van Overmeire, MD, PhD§§; and Patrick Van Reempts, MD, PhD§§,
for the EPIBEL Study Group
ABSTRACT. Objective. To determine mortality and
morbidity at discharge from the hospital of a large pop-
ulation-based cohort of infants who were born at <26
weeks’ gestation.
Methods. Perinatal data were collected on extremely
preterm infants who were alive at the onset of labor and
born between January 1, 1999, and December 31, 2000, in
all 19 Belgian perinatal centers.
Results. A total of 525 infants were recorded. Life-
supporting care was provided to 322 liveborn infants, 303
of whom were admitted for intensive care. The overall
survival rate of liveborn infants was 54%. Of the infants
who were alive at the age of 7 days, 82% survived to
discharge. Vaginal delivery, shorter gestation, air leak,
longer ventilator dependence, and higher initial oxygen
need all were independently associated with death; gen-
der, plurality, and surfactant therapy were not. Among
the 175 survivors, 63% had 1 or more of the 3 major
adverse outcome variables at the time of discharge (seri-
ous neuromorbidity, chronic lung disease at 36 weeks’
postmenstrual age, or treated retinopathy of prematu-
rity). The chance of survival free from serious neonatal
morbidity at the time of hospital discharge was <15% (21
of 158) for the admitted infants with a gestation <26
weeks.
Conclusions. If for the time being prolongation of
pregnancy is unsuccessful, then outcome perspectives
should be discussed and treatment options including
nonintervention explicitly be made available to parents
of infants of <26 weeks’ gestation within the limits of
medical feasibility and appropriateness. Pediatrics 2004;
114:663–675; extreme prematurity, mortality, morbidity,
population-based cohort.
ABBREVIATIONS. BW, birth weight; GA, gestational age; EPT,
extremely preterm; NICU, neonatal intensive care unit; OR, odds
ratio; CI, confidence interval; ROP, retinopathy of prematurity;
CLD, chronic lung disease; CS, cesarean section; IQR, interquartile
range; PDA, patent ductus arteriosus; Fio2, fraction of inspired
oxygen; CPAP, continuous positive airway pressure; NEC, necro-
tizing enterocolitis; ICH, intracranial hemorrhage; PVL, periven-
tricular leukomalacia; IP, intestinal perforation; CNN, Canadian
Neonatal Network; IPPV, intermittent positive pressure ventilation.
The critical decision to start active perinataltreatment for the fetus or neonate at the limitof viability is one of the most challenging di-
lemmas for obstetricians and pediatricians in con-
temporary perinatal practice. There is a trade off—
changing over time—whereby survival of extremely
preterm infants is achieved at the expense of disabil-
ity in later childhood. Published rates of severe neu-
rodevelopmental disability in the 1990s ranged from
17% to 45% and from 12% to 35% for infants who
were born at 24 and 25 weeks of gestation, respec-
tively.1 Therefore, individualized decisions should
be based not only on the infant’s condition at birth
but also on relevant outcome data and parental coun-
seling. However, recent information regarding the
outcome of infants who are born at extremely low
gestational age is rare, and available reports are
quickly dated. Moreover, most of the previously
published outcome data on which health care pro-
fessionals have to rely for advising parents are based
on data for which birth weight (BW) rather than
gestational age (GA) served as the basis of compar-
ison, including a significant number of more mature
small-for-gestational-age infants with a different out-
come profile and thus not useful for prenatal deci-
sions.2 In addition, most previous reports were not
population based, as they examined pooled data
over several years of a small number of infants who
were treated in different ways.3–7
The aim of the present study was to examine GA-
specific outcomes of a large population-based cohort
of infants who were born at 26 weeks’ gestation
and cared for in all 19 perinatal centers of Belgium
between January 1999 and December 2000 and to
compare the results with those of other geographic
GA-based cohorts available in the literature.8–15
METHODS
Study Population and Data Abstraction
During a 2-year period (January 1, 1999, to December 31, 2000),
data of all inborn births with a GA between 22 and 26 completed
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weeks, ie, up to 26 weeks and 6 days’ postmenstrual age, were
collected in all perinatal centers in Belgium. During the same
period, another 58 extremely preterm (EPT) infants with similar
GA were admitted to the 19 centers after postnatal transfer within
the first 24 hours. These outborn infants (16% of EPT infants
admitted) are not included in additional analysis. Belgium has a
population of 10 million people and nearly 115 000 annual
births.
GA was defined as the best obstetric estimate using the infor-
mation on the record form. The expected date of delivery was
based on the last menstrual period of the mother or on the results
of an ultrasound performed before 20 weeks’ gestation, whichever
was available. If both were available and the expected date of
delivery derived from ultrasound scans differed from that based
on last menstrual period by 14 days, then the scan gestation was
used.
A standardized data set of 82 items, including demographic
information about the mother and a large number of perinatal
data until death, was used. A list of all items collected is provided
in the Appendix. A birth, especially at the margins of viability,
may arbitrarily be reported as a live birth or later as a neonatal
death or fetal death depending on which definition is chosen by
the professionals present at birth. This will affect reporting of
mortality and outcome around this gestational age.16 Therefore,
data were collected on all pregnancies with at least 1 fetus 22
weeks’ GA showing signs of life at the onset of labor, resulting in
a birth, death, or alive and whether admitted or not to the neonatal
intensive care unit (NICU). Infants who were reported as dying
“during delivery” eventually include also those fetuses or infants
for which before birth it was unquestionably decided by the
parents and the physician(s) involved (gynecologist and/or neo-
natologist) not to resuscitate the infant at birth.
Amnionitis was suspected when at least 2 of the following
clinical signs and symptoms were present: foul-smelling vaginal
discharge or amniotic fluid, uterine tenderness, maternal and/or
fetal tachycardia, maternal fever, and leukocytosis. Definite diag-
nosis was based on histologic evidence and/or culture.
Full data collection was completed for all infants who were
admitted to 1 of the 19 Belgian NICUs and for all infants who were
still alive at the onset of labor in 14 of the 19 units. In the remaining
5 centers, data on nonadmitted neonates were not collected be-
cause of incomplete obstetric data or no access to the obstetric file.
Data Validation
Data were entered into a computer database (Filemaker Pro) by
the local neonatal staff members and sent by electronic mailing to
the coordinator (P.V.). Records with missing information were
returned twice for correction or verification. Data were regarded
as missing when after a second return and after a personal contact
with the responsible neonatologist in each unit the investigators
concluded that the data were unobtainable. Items that were am-
biguous or improbable were discussed with the person who pro-
vided the data and errors were corrected. During analysis, outliers
and any data that seemed unlikely were double-checked. The
proportional geographic distribution of our study population was
checked by the zip code of the mother’s domicile (Spearman r2 
0.67; P  .01).
Statistical Data Analysis
All analyses were performed using SPSS 11.0.17 Group differ-
ences on continuous measures were examined by the Wilcoxon
test (2 groups) and Kruskal-Wallis test (2 groups). Differences on
categorical measures were analyzed with 2 analyses or logistic
regression as appropriate. Outcomes were analyzed by 100-g BW
intervals. GA was investigated both as a continuous variable and
categorically as completed weeks. Logistic regressions were used
to identify associations among perinatal independent risk factors
and the major outcome variables (death before discharge and
serious short-term morbidity in survivors). The results are ex-
pressed as adjusted odds ratios (ORs) and 95% confidence inter-
vals (CIs). The significance level was not changed when multiple
comparisons were performed. The level of statistical significance
for all analyses was set at P  .05 using 2-tailed comparisons.
Outcomes
Clinicians were asked whether a formal decision had been
made to provide intensive care, when this decision was discussed,
and who had participated in the decision-making process. When
the decision was not to provide intensive care, the reason for that
particular decision was requested as listed in the Appendix. Insti-
tutional Review Board approval was obtained for each termina-
tion of pregnancy at the discretion of the local authorities. The
primary cause of death was recorded using standard definitions
listed in the Appendix. More than 1 cause of death could be
recorded in the database. No data were collected on postmortem
examination. Survival was calculated at 7 and 28 days after birth
and at discharge. Cerebral ultrasound scans were reported locally
and classified as to the presence and extent of hemorrhage, ven-
triculomegaly, and/or hydrocephaly and signs of leukomalacia as
listed in the Appendix. Cases with retinopathy of prematurity
(ROP) stage III and more (international classification18) and their
treatment (oxygen, cryotherapy, or laser) were noted. Oxygen
dependence and chronic lung disease (CLD) were recorded at 28
days postnatally and at 36 weeks of postmenstrual age. Special
care (nutritional or respiratory) needed at discharge from the
hospital was registered for all infants who were discharged alive.
A discretional estimate of the overall clinical neurologic state by
clinical examination at discharge was recorded locally as normal,
abnormal, suspicious, or unknown.
RESULTS
One hospital reported no live births between 22
and 26 weeks of gestation during the study period. In
the other 18 hospitals, 525 births were recorded (Ta-
ble 1). A total of 350 (66.6%) infants died. A total of
222 (42.3%) nonsurviving infants were not admitted
to the NICU, 203 (91%) of whom died after the onset
of labor or immediately at birth and 19 (9%) infants
in the delivery room after active resuscitation. Of the
303 neonates who were admitted to the NICU, 42.2%
died before discharge and 175 (57.8%) were still alive
at discharge from hospital.
Of the 525 births, 212 (40%) originated from moth-
ers who were booked at the local maternity hospital.
A total of 273 (52%) came from mothers who were
transferred prenatally or during labor to the perina-
tal center. From the 40 births that remained, the
origin was not provided.
Stay in the NICU of the 303 admitted infants ac-
counts for 19 684 hospital days, with a mean (stan-
dard deviation) of 96 (24) days for the 175 survi-





















22 72 70 (97.2) 2 (2.8) 1 (50) 1 (1.4) 1 (50) 0/2 (0)
23 71 53 (74.6) 18 (25.4) 5 (27.8) 13 (18.3) 12 (66.7) 1/18 (5.5)
24 101 36 (35.6) 65 (64.3) 11 (16.9) 54 (53.5) 35 (53.9) 19/65 (29.2)
25 115 25 (21.7) 90 (78.3) 0 (0) 90 (78.3) 40 (44.5) 50/90 (55.5)
26 166 19 (11.4) 147 (88.6) 2 (1.3) 145 (87.4) 40 (27.2) 105/147 (71.5)
Total 26 525 203 (38.7) 322 (61.3) 19 (5.9) 303 (57.7) 128 (39.8) 175/322 (54.3)
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vors (17 421 days [89%]) and a mean (standard
deviation) of 14 ( 9) days for the 128 deceased
infants (2263 days [11%]). Of the nonsurvivors, 40%
(51 of 128) died before 48 hours, 69% (89 of 128) died
before 7 days, and 89% (114 of 128) died before 28
days. The number of ventilator days was 4204 for the
group of admitted infants, 68% (2841) of whom were
used for the 175 surviving infants.
Maternal and Infant Characteristics
Of the 525 infants recorded, 154 (29%) were part of
a multiple pregnancy: 125 from a twin pregnancy (45
complete sets), 25 from a triplet pregnancy (6 com-
plete sets), and 4 from 1 complete set of a quadruplet.
Twenty-one percent of the mothers were older than
35 years at the time of delivery. Assisted reproduc-
tion techniques were used in 18% of the infants ad-
mitted. Seventy percent of the mothers of admitted
infants were primiparous and parity did not differ by
plurality (P  .45).
In only 32% of all pregnancies, no complications
were reported. Sixty-nine percent (210 of 303) of the
infants who were admitted were born after threaten-
ing preterm labor. Placental abruption and cerclage
were present in the history of 7% and 6%, respec-
tively. Preterm premature rupture of membranes
was present from the maternal history in 37% (195 of
525) of all infants recorded and in 22% (66 of 303) of
the infants admitted. Chorioamnionitis was sus-
pected in 33% (101 of 303) and proved in another 9%
(28 of 303) of the infants admitted. Preeclamptic tox-
emia was present in the history of 8%. The rates of
complications of pregnancy did not differ by gesta-
tional age. Tocolytics were used in 51% (267 of 525)
of all infants recorded and in 77% (134 of 175) of the
surviving infants. Data on the use of prenatal ste-
roids are not available in this study.
Thirty-five percent of the cesarean sections (CSs)
were multiple births. Forty-one percent (124 of 303)
of the NICU-admitted infants were born by CS. Forty
percent (30 of 79) of the admitted singletons who
were born by CS died. Secondary or urgent CS (91 of
124) was more common at higher gestation (P 
.0005). Fifty-seven percent (83 of 145) of the admitted
infants with a gestation of 26 weeks were born by CS.
CS rate varied widely among centers, ranging from
14% to 75% (median  interquartile range [IQR]: 41
 23%). There was a significant positive correlation
between CS rate and survival rate for NICU-admit-
ted infants (r2  .49, P  .001). CS rate was also
positively correlated with the admission rate for live-
born infants in 13 NICUs where informative data
were available (r2  .55 for paired data [Wilcoxon
signed rank test]; P  .05).
The proportion of liveborn infants who were ad-
mitted for intensive care rose with increasing gesta-
tion (P  .0001; Table 1). Thirty-five percent (107 of
303) of the admitted infants were part of a multiple
pregnancy. Fifty-four percent (163 of 303) of the ad-
missions were male. Seventeen percent (90 of 525) of
all infants and 7% (20 of 303) of admitted infants
were reported to have major congenital abnormali-
ties. Thirteen of the latter group died before dis-
charge. For the admitted infants, mean BW was 563,
660, 757, and 831 g at 23, 24, 25, and 26 weeks of
gestation, respectively.
Illnesses and Interventions
Clinical characteristics, interventions, and separate
outcome variables are shown in Table 2. The propor-
tion of intubated infants who had hyaline membrane
disease and/or respiratory insufficiency and re-
ceived surfactant did not increase with higher gesta-
tion (88%–93% of infants with a gestation of 24-26
weeks; P  .45). The number of ventilator days (me-
dian  IQR) of surviving infants of 24 weeks of
gestation (37  27) was significantly higher com-
pared with the duration of ventilation in infants of 25
TABLE 2. Clinical Characteristics, Interventions, and Separate Outcome Variables in NICU-Admitted Infants and Infants Discharged
Alive
NICU-Admitted Infants
(n  303), n or n/N (%)
Infants Discharged Alive
(n  175), n (%)
Major congenital malformation 20 (6.6) 7 (3.9)
Perinatal sepsis (72 h of life) 45 (15) 19 (11)
Idiopathic respiratory distress syndrome 261 (86.1) 146 (83.4)
Endotracheal ventilation 283 (93.3) 154 (87.9)
Surfactant therapy 236 (77.8) 131 (74.8)
Air leak syndrome 66 (21.7) 28 (15.9)
CLD at postnatal age of 28 d — 143 (82)
CLD at postmenstrual age of 36 wk — 78 (44.5)
Postnatal steroid therapy 139 (45.8) 103 (58.8)
Erythropoietin treatment — 31 (17.7)
ICH grade 1–2* 70/280 (24.9) 46 (26.2)
ICH grade 3–4 70/280 (24.9) 21 (11.9)
Cystic PVL 21 (6.9) 17 (9.7)
Treated hydrocephaly (permanent shunt) — 12 (6.8)
Abnormal or suspect neurologic status at discharge — 50 (28.5)
Surgical duct ligation 28 (9.2) 19 (10.8)
Treated ROP (laser or cryocoagulation) — 35 (19.9)
Surgical NEC or IP 44 (14.5) 28 (15.9)
Abdominal surgery 53 (17.4) 40 (23)
Permanent renal insufficiency† 11 (3.6) 1 (.5)
* At least 1 ultrasound scan performed in 280 of the 303 admitted infants.
† Serum level of creatinine 1.5 mg/dL at time of discharge or death.
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weeks (15 21) and 26 weeks’ gestation (6 19; P
.005). Figure 1 illustrates the proportional decrease of
ventilatory support in surviving infants.
Patent ductus arteriosus (PDA) was reported in
43% of infants who were admitted. Seventy-six per-
cent were treated with a nonsteroidal anti-inflamma-
tory drug (mainly indomethacin), 20 (15%) were
treated with medication and ligation, and 8 (6%)
were treated with ligation alone.
There was no difference in the postnatal use of
steroids with increasing gestational age or in the age
(median  IQR: 7  14 days) at which steroids were
started in infants of different maturity. Steroid ther-
apy in survivors was given for a median (IQR)
duration of 19 (8) days.
Outcomes
Death Rates, Causes of Death, and Survival
A total of 222 (42.3%) patients were not admitted
to the NICU, 203 (91%) of whom were reported to
have died after the onset of labor and 19 (9%) in the
delivery room after intentional resuscitation. Eighty-
four intrapartum deaths were late terminations of
pregnancy, mainly (68%) because of the detection of
a major congenital or hereditary fetal anomaly. Of
the 303 neonates who were admitted to the NICU,
128 died before discharge and 175 were discharged
alive from the hospital. After 1 week, 71% of the
admitted infants were still alive (Table 3). Rates of
survival for NICU-admitted infants are 62% at 28
days of age and 58% at discharge. Expressed as a
percentage of reported live births, survival to dis-
charge at 23 weeks was 5% (1 of 20), at 24 weeks
was 29%, at 25 weeks was 56%, and at 26 weeks was
72%. There is a significant intercenter variation in
survival rate of admitted infants ranging from 32% to
93% with a median (IQR) value of 52% (21). In
the 14 units that included all intentionally resusci-
tated live births (288 infants), median (IQR) sur-
vival rate (50% [17]) was significantly (P  .01) less
than the rate (64% [32]) in the units that reported
only on NICU-admitted infants (34 infants). Most
deaths in the NICU occurred early in the postnatal
course (Fig 2). The probability to survive until dis-
charge from hospital for the 1-week survivors ranges
from 20% at 24 weeks to 90% at 26 weeks of
gestation. After 28 days of survival, the chance to be
discharged alive is 83% for infants of 24 weeks up to
99% for infants of 26 weeks’ gestation (2 trend, P 
.0005 for both groups).
The primary causes of death were mainly cerebral
hemorrhage (28%), pulmonary insufficiency (27%),
infection (16%), intractable hypotension or shock
(13%), and congenital malformation (7%). A combi-
nation of respiratory insufficiency, cerebral hemor-
rhage, and/or infection accounted for 52% of the
death rate of admitted infants.
Intensive care was sustained until death in 50% (64
of 128) of the nonsurviving infants who were admit-
ted to the NICU. Life-supporting care was with-
Fig 1. Cumulative proportion of endotra-
cheal ventilatory support according to GA in
infants who were discharged alive: arrows
indicate the median duration of ventilatory
support in surviving infants of 24, 25, and 26
weeks’ gestation, respectively (24 vs 25 and
26 weeks’ gestation  25 vs 26 weeks’ gesta-
tion: P  .005).















% ( SE) of 28-Day
Survivors Discharged
From Hospital
23 14 35.7 (5) 20 ( 12) 28.5 (4) 25 ( 10) 7.1 (1)
24 54 53.7 (29) 65.5 ( 6) 42.5 (23) 82.6 ( 6) 35.1 (19)
25 90 69.9 (63) 79.3 ( 4) 62.2 (56) 89.2 ( 5) 55.5 (50)
26 145 80.6 (117) 89.7 ( 2) 73.1 (106) 99.0 ( 3) 72.4 (105)
All 303 70.6 (214) 81.7 ( 5) 62.3 (189) 92.5 ( 4) 57.7 (175)
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drawn in 39% (50 of 128), mainly because of severe
brain hemorrhage or intractable respiratory insuffi-
ciency. For the remaining 14 deaths, no answer was
provided. The results of logistic regression analyses
estimating the independent relationships between
perinatal risk factors and death in the NICU-admit-
ted infants are shown in Table 4. Vaginal delivery,
lower gestation, air leak, number of days on a respi-
rator, and higher minimal fraction of inspired oxy-
gen (Fio2) within the first 12 hours of life still re-
mained significantly associated with death in the
multivariate model. Death rate was not affected by
the use of surfactant therapy, gender, and plurality.
Major Complications of Prematurity and Morbidity
The incidence of major complications of prematu-
rity is shown in Table 2. The incidence of major
cerebral hemorrhage (grade 3–4) was inversely cor-
related with GA in the group of admitted infants (P
 .0005) but not in the survivors. CLD at 36 weeks’
postmenstrual age as the separate outcome variable
was significantly associated with GA (OR: 0.52; 95%
CI: 0.28–0.76; P  .05), surfactant therapy (OR: 2.43;
95% CI: 1.62–6.38; P  .005), and the number of days
on the respirator (OR: 1.38; 95% CI: 1.28–1.48; P 
.001) in a multivariate analysis using the same inde-
pendent variables as in the previous analysis (intra-
uterine transfer, medically assisted conception, pre-
mature rupture of membranes 24 hours, mode of
delivery, gender, gestation, BW, multiple, air leak,
endotracheal ventilation, days on the ventilator, sur-
factant, and minimal and maximal Fio2 in first 12
hours). Seventeen infants (10%) were discharged on
home oxygen therapy (n  12) or other respiratory
support (1 continuous positive airway pressure
[CPAP], 1 positive pressure ventilation, and 3 trache-
ostomies).
Threshold retinopathy was diagnosed in 35
(19.9%) patients. Six additional patients were treated
with oxygen for prethreshold disease in line with the
STOP-ROP study.19 Laser therapy was used in 7
infants and cryotherapy in 28 other infants. BW and
GA were significantly lower in threshold cases com-
pared with survivors without ROP (P  .004 and 
.02, respectively). Additional analysis of indepen-
dent risk factors for threshold retinopathy in this
cohort of EPT infants is reported by Allegaert et al.20
Hearing deficit was diagnosed in 9 (5%) patients
by brainstem evoked response audiometry and was
suspected in another 16 (9%) infants. However, 23%
(41 of 175) of all survivors either were not screened
for audition or data were unknown.
An outcome scale to discharge was constructed
(Fig 3). Short-term “intact” survival was pinned
down as a survival without neurologic sequelae and
without specific intensive care complications at the
time of hospital discharge. Seventy-two percent,
56%, and 35% of the admitted infants with a gesta-
tional age of 26, 25, and 24 weeks, respectively, were
discharged alive. After substraction of all surviving
infants with serious neurologic sequelae (see legend
to Fig 3), the remaining groups represent 50%, 32%,
and 19% of the infants admitted, respectively. Fi-
Fig 2. Survival distributions for GA (P  .0001) of all infants who
were admitted to NICUs (n  145 at 26 weeks, 90 at 25 weeks, 54
at 24 weeks, and 13 at 23 weeks).
TABLE 4. Results of Univariate and Multivariate Analyses of Perinatal Risk Factors Associated
With Death Before Discharge in 303 NICU-Admitted Infants
Variable





OR (95% CI) P Value OR (95% CI) P Value
Intrauterine transfer 1.25 (0.70–2.22) .444
Medically assisted conception 0.92 (0.40–2.14) .859
PROM (24 h) 0.69 (0.33–1.45) .335
CS vs vaginal delivery 0.40 (0.22–0.74) .003 0.41 (0.23–0.74) .003
Male gender 1.17 (0.65–2.10) .588
Gestation (per wk) 0.36 (0.25–0.50) .0005 0.35 (0.23–0.51) .0005
BW (per 100 g) 0.99 (0.99–1.00) .49
Multiple 1.10 (0.57–2.14) .761
Air leak syndrome (48 h) 2.01 (1.02–3.98) .044 2.13 (1.10–4.12) .024
Endotracheal ventilation 1.24 (0.30–5.08) .758
Days on the ventilator 0.96 (0.94–0.98) .001 0.96 (0.95–0.98) .001
Surfactant therapy 1.43 (0.62–3.28) .396
Minimal Fio2 12 h 0.20 (0.10–0.40) .0005 0.18 (0.09–0.34) .0005
Maximal Fio2 12 h 0.59 (0.30–1.13) .114
PROM indicates premature rupture of membranes.
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nally, after consecutive deduction of infants with
specific NICU complications (sequentially minus
treated ROP, CLD, duct ligation, and surgical necro-
tizing enterocolitis [NEC] or gut perforation) from
the corresponding groups of surviving infants free of
neurologic sequelae, 28% of the infants with a gesta-
tion of 26 weeks could be defined as short-term intact
survivors. For the infants of 25 and 24 weeks’ gesta-
tion, 7% and 4% are left as intact survivors, repre-
senting 6 of 90 and 2 of 54 admitted infants, respec-
tively.
Short-term outcome of the 175 infants who were
discharged alive in different NICUs is shown in Fig
4. Fifty-eight percent (20) is the median (IQR) rate
of survival without serious neuromorbidity. The me-
dian (IQR) survival rate without any major neuro-
logic sequelae and also free of NICU-related compli-
cations is 20% (21).
All 3 of the major adverse outcomes—serious neu-
romorbidity, CLD at 36 weeks’ postmenstrual age,
and treated ROP—occurred in 10 (6%) infants, and 2
of the 3 adversities occurred in 40 (23%) other infants
(Fig 5). One of these 3 major adverse outcomes was
observed in another 61 (20%) infants who were dis-
charged from the hospital. The occurrence of 1 of
these major adverse outcome variables was signifi-
cantly higher in the group of admitted infants with a
gestation of 24 to 25 weeks compared with the ad-
mitted group with a gestational age of 26 weeks (2,
P  .014). Of the 35 surviving infants with threshold
ROP, 74% (26 of 35) had at least 1 major comorbidity.
Surgical duct ligation was an isolated specific event
in 4 surviving infants, and laparotomy for NEC or
bowel perforation was a single complication for 9
other infants. Of the 19 surviving infants with a
surgical duct closure, 74% were oxygen dependent at
36 weeks’ postmenstrual age.
Logistic regression analysis was performed using
the same independent variables as in the previous
analysis with, at this time, serious neuromorbidity
(intracranial hemorrhage [ICH] grade 3 or 4, cystic
periventricular leukomalacia [PVL], and discharge
disability present or suspect) and typical NICU-re-
lated complications (treated ROP, CLD at 36 weeks’
Fig 3. Cumulative short-term outcome scale at the time of discharge for admitted infants with a GA of 24 to 26 weeks. Severe neurologic
sequelae are ICH grade 3 and 4 or shunted hydrocephaly (ICH 3), cystic PVL (cPVL), and discharge disability present or suspected
(disdis). NICU-related complications are treated ROP (tROP), CLD at 36 weeks’ postmenstrual age (CLD36), surgical ligation of PDA
(sPDA), and surgical NEC (sNEC) or IP.
Fig 4. Short-term outcome of the 175 infants who were discharged
alive: box-and-whisker plots (median  IQR) for survival without
major neuromorbidity (58%  20; A), survival without severe
neurologic sequelae and without tROP (46%  21; B), survival
without neuromorbidity, tROP, and CLD (28%  23; C), and
survival without neuromorbidity, tROP, CLD, and sPDA or
NEC/IP (20%  21; D).
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postmenstrual age, PDA ligation, and surgical NEC/
intestinal perforation [IP]) as separate outcome vari-
ables (Table 5). Multivariate analysis showed a sig-
nificant association of the duration of endotracheal
ventilation with serious neuromorbidity in the group
of surviving EPT infants. In the multivariate model,
2 variables—days on the respirator and maximal
Fio2 during first 12 hours—were significantly asso-
ciated with the occurrence of specific NICU-related
complications.
Growth Rate
BW and body weight at the time of discharge from
the hospital were plotted on a population-specific
growth chart21 and on Lubchenco’s fetal growth
curve22 for 153 of the 175 surviving infants for whom
both weight data and time intervals were available
(Fig 6). Postnatal weight gain expressed as g/kg/day
(median  IQR) during the hospital stay in 96 sur-
vivors of 26 weeks’ gestation (10.7  2.6) was not
significantly different from that in 57 surviving in-
fants with a gestation of 24 to 25 weeks (10.3  3; P
 .85). Sixteen percent (24 of 153) of these survivors
were small for gestational age (BW 10th centile).
Body weight at discharge was 10th centile (65 of
120) of the population-specific intrauterine growth
curve and, for survivors discharged at a postmen-
strual age 42 weeks, 10th centile (25 of 33) of the
gender-specific postnatal Euro-Growth chart.23
Overall growth restriction at the time of discharge
was present in 59% (90 of 153) of the infants.
DISCUSSION
The overall survival rate of a population-based
cohort of liveborn infants who were 26 weeks’ GA
was 54%. Mortality was high in the first few days at
all GAs but most impressive in infants below 24
weeks’ gestation. GA-specific survival curves of this
geographic cohort should help physicians in their
discussions with parents on survival probabilities
and policy makers in planning resource allocation
(Fig 2, Table 3). Thirty-three percent of the survivors
showed serious neuromorbidity, and only 37% were
free of major neonatal morbidity (major neuromor-
bidity, CLD at 36 weeks of postmenstrual age, and
treated ROP).
Many studies limit and base outcome data of EPT
infants on BW, confounding the effects of extremely
preterm birth with those of intrauterine growth re-
striction. Moreover, many previous studies—besides
not being population-based—omitted (or did not in-
clude) termination of pregnancy, fetal deaths, or de-
livery room deaths, thus exaggerating survival by
100% and 56% at 23 and 24 weeks, respectively, as
stated by Evans and Levene.24 This type of selection
bias could lead to inaccurate counseling of pregnant
women as to the survival potential of a possible
viable or nonviable fetus. In the present study, 13 of
the 18 units reported not only on NICU admissions
but also on all live births, intrapartum deaths, and
terminations of pregnancy. A significant difference
in survival rate was calculated depending on the
denominator used.
Chan et al11 emphasized the impact of EPT infants
on resource use consuming 11% of total NICU pa-
tient days and 20% of mechanical ventilator use. Our
Fig 5. Diagram showing the incidence of multiple major morbid-
ity in all survivors (n  175) to discharge from the hospital: major
neuromorbidity (ICH grade 3, cPVL, hydrocephaly treated by
permanent shunt, and discharge disability present or suspected),
CLD at 36 weeks, and treated ROP.
TABLE 5. Results of Univariate and Multivariate Analyses of Prenatal and Postnatal Risk Factors Associated With Serious Neuro-
morbidity and Specific NICU-Related Complications as Separate Outcomes (Defined in Text) in the 175 Surviving EPT Infants
Independent Risk Factor
(All Yes/No Unless Stated)
Outcome Serious Neuromorbidity Outcome NICU-Specific Complications
Univariate Analysis Multivariate Analysis Univariate Analysis Multivariate Analysis
OR (95% CI) P OR (95% CI) P OR (95% CI) P OR (95% CI) P
Intrauterine transfer 0.99 (0.48–2.02) .98 0.78 (0.34–1.80) .566
Medically assisted conception 1.95 (0.66–5.74) .22 2.98 (0.75–11.13) .122
PROM (24 h) 0.46 (0.18–1.14) .09 0.83 (0.30–2.30) .731
CS vs vaginal delivery 0.56 (0.25–1.28) .17 0.42 (0.17–1.06) .067
Male gender 1.08 (0.52–2.22) .83 1.22 (0.53–2.80) .636
Gestation (per wk) 0.91 (0.61–1.35) .66 0.97 (0.61–1.53) .905
BW (per 100 g) 1.00 (0.99–1.00) .24 0.99 (0.99–1.00) .050
Multiple 0.63 (0.27–1.47) .29 0.53 (0.20–1.40) .201
Air leak syndrome 1.20 (0.46–3.11) .70 5.32 (1.06–26.71) .042
Endotracheal ventilation 0.67 (0.14–3.14) .61 1.68 (0.39–7.23) .485
Days on the ventilator 1.03 (1.00–1.05) .01 1.03 (1.01–1.05) .002 1.07 (1.02–1.13) .007 1.07 (1.02–1.12) .002
Surfactant therapy 1.76 (0.61–5.05) .28 0.66 (0.21–2.07) .481
Minimal Fio2 12 h 2.43 (0.73–8.05) .14 2.32 (0.56–9.62) .244
Maximal Fio2 12 h 0.53 (0.24–1.16) .11 0.32 (0.13–0.76) .010 0.37 (0.17–0.79) .011
PROM indicates premature rupture of membranes.
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EPT infants represent only 2% of all NICU admis-
sions in Belgium, but they occupy 10% of the 332
NICU beds available. During the study period, 16%
of all mechanical ventilator days in Belgian NICUs
are “consumed” by infants with a GA 26 weeks
(data provided by the Belgian Society of Neonatolo-
gists and Pediatric Intensivists). However, in NICUs,
most expenditure, even among the smallest infants,
is allocated to the surviving infants, in contrast to
adult medical intensive care for the oldest patients at
greatest risk, where more than half of the intensive
care bed-days are spent on those who will not sur-
vive.25
Thirty-five percent of the 303 infants who were
admitted were part of a multiple pregnancy. In other
population-based studies (United Kingdom, Canada,
New Zealand, France), this number ranged from 23%
to 29%.8,11–13 This strong association of extreme pre-
maturity with multiple-gestation pregnancies in dif-
ferent surveys suggests a probable link with the use
of assisted reproduction techniques. However, mul-
tiple gestation in these EPT infants was not associ-
ated with outcome variables (survival and short-
term major neuromorbidity or NICU-specific
complications). This is in accordance with the results
of a large single-center study in which neonatal out-
comes (survival, ICH, CLD, PDA, NEC, and ROP) of
EPT infants from multiple gestations were not sig-
nificantly different from those of singletons.26 A high
rate of obstetric complications was found particu-
larly for preterm premature rupture of membranes
and amnionitis similar to the findings in the EPICure
study.8 Tocolytics were used liberally (70%) in the
patients who were admitted, in contrast with only
22% of the mothers who were admitted in the EPI-
Cure cohort.8 Contrary to the UK-Ireland cohort, we
could not find any association between the use of
tocolytics and survival, incidence of brain ultrasound
abnormalities, or CLD. Because the prevalence of
tocolytics’ use is so obviously different in these 2
study groups, other yet unknown variables may
have been involved to explain these divergent re-
sults.
CS was associated with higher survival in our
study group of admitted patients but not with short-
term outcomes (serious neuromorbidity and specific
NICU complications). In contrast, CS was not asso-
ciated with higher survival in the EPICure cohort.8 In
the Canadian geographic cohort of infants from 22 to
25 weeks’ gestation, the CS rate was 33% overall and
47% for infants of 25 weeks’ GA.11 The Canadian
NICU Network found that abdominal delivery in
EPT infants was associated with less severe ICH.27 In
a recent large, single-hospital study on 278 deliveries
at 22 to 25 weeks, CS was associated with increased
in-hospital mortality.4 In a prospective observational
multicenter study on 713 singleton births, Bottoms et
al28 reported that the willingness to perform a CS
between 22 and 25 weeks’ gestation for fetal indica-
tions was linked to an increased chance of survival
with serious morbidity. We showed a higher rate of
survival in admitted infants after CS and a correla-
tion of the CS rate with the admission rate of liveborn
EPT infants. This may either mean the willingness of
the obstetrician to perform a CS with an ensuing
active commitment of the neonatologist to—at least
temporarily—save the life of the EPT infant or that
the wishes of the parents and an active treatment
attitude of the neonatologist—whether based on sup-
posed better outcomes locally or not —induce less
reluctance on the side of the obstetrician to perform
a CS for the previable infant. The data of this study
do not permit any additional conclusion on this sub-
ject. However, it illustrates that the approach to ob-
stetric management significantly influences the out-
come of EPT infants and that in these cases, patients
and physicians should be aware of the impact of that
approach. For the time being, systematic review of
controlled trials up to 2003 shows that a policy of
elective CS delivery in the very small infant un-
doubtedly increases the perioperative risks of mater-
nal morbidity, but it remains unclear whether these
are offset by benefits for the infant. Recruitment dif-
ficulties will probably hamper a clear answer to this
question in the near future.29
As in the UK-Ireland cohort, we did find an im-
Fig 6. BW and body weight at discharge from the hospital for surviving infants of 26 weeks’ gestation (right-sided diagram) and 24 to
25 weeks (left-sided diagram) plotted on a population-specific growth chart (p10 and p90 intrauterine growth standards for Belgian infants
with permission from Devlieger et al21 and for comparison on Lubchenco’s fetal growth curve22 [stippled lines for 10th and 90th centiles]).
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portant number of admitted infants (25 [8%]) with a
BW below the recommended lower limit of 500 g set
by the World Health Organization for routine collec-
tion of perinatal data.8 Nine (36%) of these 25 infants
survived to be discharged from hospital.
The association of early clinical condition variables
(early air leak and a high minimal Fio2 in the first 12
hours) with death, as well as with serious neuromor-
bidity and specific complications, suggests that these
markers of risk can at least partially help in early
postnatal informed decision making, ie, of consider-
ing withdrawal of intensive care. Lower gestation is
significantly associated with death but not with ma-
jor neuromorbidity or with characteristic NICU com-
plications in their most severe form of presentation.
In 39% (50 of 128) of the admitted infants who did
not survive, withdrawal of curative intensive care
was planned. Differences in this end-of-life decision
policy may partially explain the large variation in
survival rate between units. This may also be the case
as seen in the large interhospital variation in delivery
room survival rates (range: 41%–82%) as demon-
strated by Chan et al11 and in the present study
(range: 33%–75%). Of 106 informative cases (data not
shown) in 12 different NICUs, we could also find
large differences in ethical practice with regard to the
decisions of withholding curative care in the delivery
room. In some units, a well-established GA of 24
completed weeks was an elective criterion for non-
resuscitation. In other units, this decision was never
or seldom taken. Parental refusal to initiate full re-
suscitation was exceptional (2 cases) and reported in
only 1 NICU. From our data, it seems that parenchy-
mal cerebral bleeding contributed largely to the
number of infants who died as a result of withdrawal
of intensive care, thereby significantly reducing the
numbers of survivors with major ICHs from 25% in
the patients who were admitted to 12% in survivors.
This was also clearly demonstrated in the EPICure
study.8
In the Canadian cohort11 and the present study,
almost two thirds of the surviving infants received
postnatal steroids for prevention of CLD. Seventy-
two percent of the EPICure cohort survivors received
steroids postnatally.8 It is important to realize that all
infants in these studies were born before the new
millennium. It is since then almost clear that the risks
of this treatment in currently used doses outweigh
the benefits.30
Although on physiologic grounds the absence of
any beneficial effect of surfactant treatment before 26
weeks might be presumed, the administration of sur-
factant has been estimated to benefit some EPT in-
fants.4,31,32 Eighty-four percent of admitted infants in
the EPICure study8 and 78% in ours received surfac-
tant, but death rates were not affected by the use of
surfactant. This is in contrast to the retrospective
study by Ferrera et al32 reporting an improvement in
survival from 55% to 73% for the infants (23–26
weeks) who were treated compared with those who
were not treated with surfactant. A large retrospec-
tive cohort study of 891 liveborn infants of 23 to 26
weeks’ gestation (421 presurfactant and 470 postsur-
factant) in Canada showed no secular change in
overall mortality since the introduction of rescue
therapy with natural surfactant.33 In both the EPI-
Cure and our EPIBEL study, the use of surfactant
was associated with a higher frequency of CLD at 40
and 36 weeks’ postmenstrual age, respectively. The
question of routinely adopting a policy of treating all
infants of 23 to 26 weeks’ gestation with surfactant
undoubtedly requires additional exploration.
Population-based surveys on infants who are born
before 28 weeks’ gestation are scarce worldwide.
Table 6 is an overview of recently published GA-
specific population-based surveys of EPT infants
who were born since 1990. The survival rates of our
population-based cohort are within the range of
other European and Australian surveys. However,
the survival rates of liveborn EPT infants in a large
geographic survey of 17 Canadian NICUs were re-
markably higher than the average figures from Eu-
ropean and Australian data.11 These data should be
interpreted cautiously as they almost exclusively
come from large tertiary-level regional referral cen-
ters recruiting significant numbers (mean of 30 in-
fants 25 weeks’ gestation per year) of EPT infants
out of 22 million people. In our survey, only 6 of 19
NICUs report on 10 admissions per year of infants
with a GA 26 weeks and 5 units on 5 survivors
yearly, the highest number in a single unit being 20.
These figures emphasize the need for aggregated
data to provide reliable information for caregivers
and parents to make informed treatment decisions
with the best available information. A recent review
of the world literature by Hack and Fanaroff re-
vealed that in the 1990s, survival ranged from 2% to
35% at 23 weeks’ gestation. At 24 weeks’ gestation,
TABLE 6. Rates of Survival for EPT Liveborn Infants (23–25 Weeks) in Population-Based Surveys for Infants Born After 1990
Reference Region Year of Birth Rate of
Survival








1 World review 1990–1999 2–35 17–58 35–85
12 New Zealand 1998–1999 At discharge 167 (20–26) 9 72 (24–25 wk)
11 Canada 1996–1997 At discharge 949 17 44 68
13 France 1997 At discharge 207 0 31 50
9 Wales 1993–1994 At 1 y 4 26 58
10 N. England 1991–1994 At 1 y 2 17 35
8 UK-Ireland 1995 At discharge 1289 (21–25) 11 26 44
14 Australia 1991–1992 At 2 y 401 (23–27) 10 33 58
15 Australia 1992–1993 At 1 y 614 (20–27) 2 31 49
Present study Belgium* 1999–2000 At discharge 322 (22–26) 5 29 55
* Data on nonadmitted infants were not collected in 5 units.
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the range was 17% to 58%, and at 25 weeks’ gesta-
tion, the range was 35% to 85%.1
Most of the typical complications of prematurity
(ICH, PVL, hydrocephalus, ROP, and CLD) are well-
known antecedents of later disability in childhood.
Because of the known variability in interpretation for
the less severe cases in multicenter studies, we ana-
lyzed only the most severe cases reported. Among
the 54% (175 of 322) of this study population of
liveborn infants (GA 26 weeks) who were dis-
charged from the hospital, 63% (111 of 175) had 1 or
more of the 3 major adverse outcome variables (se-
rious neuromorbidity, CLD at 36 weeks’ postmen-
strual age, or treated ROP). The present study exam-
ined infants who were 1 week more mature (26
weeks) versus 26 weeks for the EPICure8 and Ca-
nadian Neonatal Network (CNN) studies.11 Thus,
62% of the surviving infants in the EPICure study
had 1 of the 3 major adverse outcome variables.
Likewise, severe ROP is similar in rate (14.6%, 17%,
and 19.9% for EPICure, CNN, and EPIBEL, respec-
tively) but with 1 week of difference. Not withstand-
ing the advanced maturity in the EPIBEL study, the
figures for CLD at 36 weeks’ postmenstrual age seem
to show a disproportionally higher rate in the EPI-
Cure data: 73% (231 of 314) compared with the 51%
(242 of 475) in CNN and 44% (78 of 175) in EPIBEL
data. Also, diverging criteria for the lower limit of
arterial oxygen saturation used in maintaining
chronic oxygen therapy may have interfered with the
incidence of CLD observed. In the EPICure group,
31% of the infants were discharged from the hospital
with oxygen therapy, contrasting with only 7% (12 of
175) in the EPIBEL infants. Severe cerebral ultra-
sound abnormalities were obvious in a similar num-
ber of infants from the discharged EPICure cohort,
EPIBEL, and CNN survey (17%, 17%, and 19%, re-
spectively).
The overall neonatal morbidity rate is very high in
EPT infants (Fig 7). In the large Canadian 1996–1997
cohort, 63% (475 of 754) of the NICU-admitted EPT
infants survived, but only 23% (109 of 475) of the
survivors and 14% of the infants who were admitted
did so without major morbidity defined as the pres-
ence of CLD, NEC, grade 3 intraventricular hem-
orrhage, or grade 3 ROP.11 Morbidity-free survival
increased from 11% of survivors at 23 weeks to
29% at 25 weeks. In the New Zealand cohort of
high-risk infants who were born in 1998–1999, the
survival rate for NICU-admitted infants of  26
weeks’ gestation was 68% (114 of 167). Thirty-eight
percent (43 of 114) of the survivors and 26% of the
infants who were admitted were discharged without
major neonatal morbidity. Morbidity-free survival
was 25% (2 of 8) for the survivors of 24 weeks and
39% (41 of 106) for infants of 24 and 25 weeks’
gestation.12 Major morbidity at discharge was de-
fined here as the presence of CLD, definite NEC,
grade 3 intraventricular hemorrhage, PVL, poren-
cephalic cyst, hydrocephalus, or grade 3 ROP. The
survival rate was 39% (314 of 811) in the EPICure
cohort of NICU-admitted infants, and the compara-
ble rate of survival without major morbidity was
38% (119 of 314) of the survivors and 15% of the
NICU-admitted infants.8 In the EPIBEL cohort, the
corresponding figures for infants of 26 weeks’ ges-
tation are a survival rate of 44% (70 of 158) and free
of comparable serious neonatal morbidity in 30% of
the survivors and 13% (21 of 158) of the admitted
group. Considering survival free of serious neonatal
morbidity, the results of most of these geographic
cohorts suggest a potential higher risk of neonatal
morbidity with improved survival in EPT infants. A
rise in neonatal morbidity and later disability in
childhood with improved survival leading to no sig-
nificant change in the number of normal survivors
(16% vs 14%) as the proportion of the original pop-
ulation was observed recently as an alarming devel-
opment comparing the outcome of 192 EPT infants in
a large single-center study during an 11-year peri-
od.34 Near universal initiation of intensive care in a
population-based cohort of EPT infants (23–26
weeks’ gestation) who were born during the mid-
1980s in central New Jersey (n 146), compared with
selective initiation of intensive care for a comparable
group of EPT infants in the Netherlands (n  141),
Fig 7. Overall survival rate and survival rate free of major neonatal morbidity at discharge in NICU-admitted infants of 26 weeks’
gestation in recently published population-based cohorts of EPT infants (Canada,11 New Zealand,12 and UK-Ireland8).
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was associated with a doubling of survival (46% vs
22%) but a 4 times higher prevalence of disabling
cerebral palsy among survivors (17.2% vs 3.4%).35
Although markers of major neonatal morbidity are
well-known antecedents of later disability in child-
hood, in-hospital morbidity is not equivalent to
childhood disability. In current published literature,
rates of severe disability vary between 17% and 45%
for those who are born at 24 weeks of gestation and
between 12% and 35% at 25 weeks.1 Disability rate
for the EPICure infants at the median age of 30
months corrected for GA was 51% (159 of 314), and
23% had severe disability.36 However, follow-up at
these early ages may not discern all impairments as
in middle to late childhood more disability may be-
come apparent.37 Neonatal health status is an impor-
tant variable indicating neurocognitive and school
performance outcomes in low BW infants.37 The sig-
nificance of these findings for the future health and
development of the children in our study will be-
come apparent only after additional follow-up in
progress.
Postnatal growth during the NICU stay of this
cohort of EPT infants did not achieve even the lower
end of what is reported for intrauterine weight gain,
which is 14 to 20 g/kg/day.38 Almost every infant
showed a major shift to the right on the reference
chart, and nearly two thirds of the survivors devel-
oped moderate to severe malnutrition during the
hospital stay (Fig 6). Recent studies suggest that cu-
mulative nutritional deficit during the early weeks of
life is the major determinant of postnatal growth
deficit39 and that early aggressive nutrition including
high protein and energy supplies from the first day
of life allowed improvement in postnatal growth in
EPT infants.40 Nevertheless, appropriately designed
interventional studies are still needed to evaluate the
safety and the medium- and long-term benefit of
such a nutritional policy.
No institution in Belgium has a large experience
with survival and long-term outcome data for EPT
infants, compared with neonatal referral centers in
Australia and North America. Survival free of major
morbidity in this vulnerable patient group is so poor
that it can be argued that additional centralization
would enable more experience to be gained in a
restricted number of tertiary-level NICUs. Also, fear
remains as higher survival rates for infants with
borderline viability may be achieved only at the ex-
pense of disability in childhood. Whether quality of
life could be improved remains to be proven. Out-
born EPT infants have poorer outcomes than inborn
infants, even after adjustment for differences in base-
line population risks and admission illness severi-
ty.11,41 As in Belgium still 16% of these EPT infants
are transferred postnatally, a more consistent referral
policy could be one more possible improvement in
perinatal care. Consistently and undoubtedly clear
from all population-based cohorts and also single-
center studies of EPT infants is that outcome im-
proves markedly between 24 and 26 weeks. There-
fore, all efforts should by priority be focused on
prolonging pregnancy. New potent tocolytics with
fewer side effects for mother and fetus, such as oxy-
tocin receptor antagonists, seem to be promising in
delaying advancement of EPT labor.42 From the data
on survival and neonatal morbidity of this and other
cohort studies of EPT fetuses and infants, for the time
being, it can be concluded that if prolongation is
unsuccessful, then outcome perspectives should be
discussed and treatment options including noninter-
vention explicitly be made available to parents of
infants of 26 weeks’ gestation within the limits of
medical feasibility and appropriateness.43,44 How-
ever, as there seems to be a continuing trend toward
improved outcomes, longitudinal studies will re-
main important for monitoring continuing changes
in EPT outcomes.11
APPENDIX
The following are data items that are included in
the standardized form for all inborn infants who are
admitted to a NICU. Items that require an answer
yes or no are indicated y/n, and ranges of options
are given in parentheses. At the end of the record,
there is an opportunity for the information to be
amplified with free text.
For all 525 records: perinatal center number; year
of admission; date of birth; date of admission; moth-
er’s birthday; zip code of mother’s home; origin
(inborn, inborn–antenatal transfer, inborn–intrauter-
ine transfer); conception (spontaneous, insemination,
hormonal induction, in vitro fertilization, unknown);
number of previous pregnancies (G); number of
live births (P); complications of pregnancy (none,
cerclage, abruptio placentae, diabetes, hospitaliza-
tion during third trimester, hypertension after week
20, threatening preterm labor, placenta previa, pre-
eclampsia, other major disease, unknown); tocolysis
(none, inapplicable, betamimetics, indomethacin,
other nonsteroidal anti-inflammatory drugs, MgSO4,
antibiotics, unknown); interval rupture of mem-
branes (peripartum, uncertain, 12 hours, 12–24
hours, 24 hours–7 days, 7–14 days, 14 days, un-
known); hydramnion (normal, anhydramnion, oligo-
hydramnion, polyhydramnion, unknown); amnion-
itis (none, yes, suspect, unknown); modus of delivery
(spontaneous vaginal, vaginal breech, elective CS,
urgent or secondary CS, instrumental delivery, CS
after instrumental traction, other); gender (boy, girl,
undetermined); GA (completed weeks); Apgar
scores at 1 and 5 minutes, respectively; resuscitation
(none, bag and mask, endotracheal ventilation, per-
fusion and/or drugs, cardiac massage, no data); BW
(grams); multiple pregnancy (no, 1 of twins, 2 of
twins, etc, unknown); congenital anomalies (n/y);
infection (none, fetal, perinatal [72 hours of life],
unknown); why intensive care was not provided (in-
applicable; because GA 23 weeks; because GA was
23 or 24 weeks; refusal of parents; decided by parents
and gynecologist; decided by parents and neonatol-
ogist; decided by parents, gynecologist, and neo-
natologist; other [please fill in comments]; died in-
trapartum; unknown); acquired gastrointestinal
disorders (none, NEC [Bell criteria stage II], gastro-
intestinal perforation[s], gastrointestinal hemor-
rhage, prolonged paralytic ileus, meconium disease,
inguinal hernia[s], other); conjugated hyperbiliru-
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binemia (none, surgical condition, parenteral nutri-
tion associated, infection, error of metabolism, idio-
pathic or nonclassified, other); days of total
parenteral nutrition; start of enteral feeding; feeding
type (mother’s milk, formula, mixed); abdominal
surgery (none, intestinal surgery, urogenital surgery,
other); intestinal surgery (intestinal surgery for NEC,
intestinal surgery for gut perforation, emergency
surgery for inguinal hernia, elective surgery for in-
guinal hernia, other); intestinal sequelae (none, yes,
dead, unknown); type of sequelae (inapplicable,
stoma during hospital stay, stoma at discharge,
[semi]elementary nutrition at discharge, other);
weight at discharge/death; primary respiratory dis-
order(s) (none, hyaline membrane disease, acquired
pneumonia, congenital pneumonia, pulmonary hem-
orrhage, persistent pulmonary hypertension, lung
edema, chronic amnion leak syndrome, other); air
leak (none, unilateral pneumothorax, bilateral pneu-
mothorax, interstitial emphysema, pneumomediasti-
num, pneumopericardium, gaseous embolism, oth-
er); endotracheal ventilation (none, yes, inapplicable,
unknown); days of endotracheal ventilation; surfac-
tant (y/n; prophylactically or rescue?); minimal (in-
applicable, 40%, 41%–60%, 61%–90%, 91%–100%,
unknown) and maximal (inapplicable, 40%, 41%–
80%, 81%–90%, 91%–100%, unknown) Fio2 during
first 12 hours of life; number of days on nasal CPAP;
postnatal day nasal CPAP was arrested; last day of
oxygen therapy; CLD at 28 days postnatally (none,
type I, type II, inapplicable) and type of treatment
provided (inapplicable, ambient air, Fio2 40%, Fio2
40%, CPAP, intermittent positive pressure ventila-
tion [IPPV]); CLD at 36 weeks of postmenstrual age
(none, type I, type II, inapplicable) and type of treat-
ment provided (inapplicable, ambient air, Fio2
40%, Fio2 40%, CPAP, IPPV); systemic steroid
therapy (none, yes, inapplicable, unknown); postna-
tal age (days) at the onset of steroid treatment, num-
ber of steroid therapy days; persistent ductus arteri-
osus (none, fluid restriction/diuretics, indomethacin,
other nonsteroidal anti-inflammatory drugs, sur-
gery); use of inotropics (none; prophylactic dopa-
mine5 g/kg/min; dopamine therapeutic dose5
g/kg/min; therapeutic dose of dopamine and do-
butamine; therapeutic dose of dopamine, dobut-
amine, and other; other; unknown); number of trans-
fusions; erythropoietin therapy (none, yes, no data);
thoracic surgery (none, cardiac surgery, pulmonary
surgery, esophageal surgery, other); cardiac surgery
(ductus arteriosus ligation, palliative shunt, correc-
tive cardiac surgery, other); renal insufficiency (none,
transitory, prolonged (at postnatal age7 days), per-
manent ( at discharge); biochemical disorders
(none, persistent or recurrent hypoglycemia [40
mg/dL], persistent severe hyperglycemia [200
mg/dL], persistent moderate hyperglycemia [150
mg/dL], severe metabolic acidosis [maximal base
deficit15], moderate metabolic acidosis [maximal
base deficit 10], severe hyponatremia [125
mEq/L], moderate hyponatremia [130 mEq/L], se-
vere hypernatremia [160 mEq/L], moderate hyper-
natremia [150 mEq/L], other); hydrocephaly (none,
external, communicating, supratentorial); type of
treatment (y/n) for hydrocephaly (inapplicable, ex-
ternal drain, Rickham catheter, ventriculoperitoneal
shunt, ventriculoatrial shunt, endoscopic therapy, se-
rial lumbar punctures  drugs, other); cerebral hem-
orrhage (none, grade 1 [subependymal], grade 2
[limited intraventricular], grade 3 [large intraventric-
ular hemorrhage with ventricular dilatation], grade 4
[frontoparietal intraparenchymatous echodensity],
other, no data); leukomalacia (none, isolated
echodensities 7 days, regular echodensities  ven-
triculomegaly, irregular echodensities and no ven-
triculomegaly, irregular echodensities and ventricu-
lomegaly, cystic PVL, cystic subcortical/mixed
leukomalacia); treatment of indirect hyperbiliru-
binemia (none, phototherapy, 1 exsanguinotransfu-
sion, multiple exsanguinotransfusions, intravenous
immunoglobulins, other); clinical evaluation at dis-
charge (normal, abnormal, suspicious, dead, un-
known); neurosensorial hearing deficit (none, yes,
uncertain, not tested, dead, unknown); ROP stage
III (none, yes, not tested, dead, unknown); ROP
treatment (inapplicable, oxygen, cryotherapy, laser,
unknown); date of discharge; type of discharge (in-
applicable, home, referring neonatal or pediatric
unit, other NICU, internal transfer to the pediatric
department, center for functional readaptation, died,
other, unknown); special care at discharge (none,
inapplicable, oxygen therapy, CPAP, IPPV, tracheos-
tomy, tracheostomy and IPPV, parenteral nutrition,
tube feeding, partial tube feeding, gastrostomy feed-
ing, other); death (y/n); date of death; causes of
death (inapplicable, congenital malformation, peri-
natal asphyxia, obstetric trauma, infection, cerebral
hemorrhage, leukomalacia, shock, respiratory insuf-
ficiency, inborn error of metabolism, fetal hydrops,
perioperative complication, iatrogenic cause, unex-
pected death, unexplained, other cause(s); place of
death (inapplicable, NICU, delivery room, cardiac
surgery unit, pediatric department, other hospital
department, referring hospital, babylance, at home,
unknown); application of care (inapplicable, applica-
tion of curative care until death, abstention, with-
drawal of curative care, unknown).
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